Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma

NCT04066504 · clinicaltrials.gov ↗

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Basal Cell Carcinoma

Interventions

DRUG: sonidegib

Sponsor

Sun Pharmaceutical Industries Limited